Drug treatment of lipid disorders

被引:648
作者
Knopp, RH [1 ]
机构
[1] Univ Washington, NW Lipid Res Clin, Seattle, WA 98195 USA
关键词
D O I
10.1056/NEJM199908123410707
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:498 / 511
页数:14
相关论文
共 142 条
[1]  
ABRAMOWICZ M, 1998, MED LETT, V40, P117
[2]  
ABRAMOWICZ M, 1996, MED LETT, V38, P67
[3]   REDUCTION OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE, APOLIPOPROTEIN D AND THE LP(A) LIPOPROTEIN WITH THE ANABOLIC-STEROID STANOZOLOL [J].
ALBERS, JJ ;
TAGGART, HM ;
APPLEBAUMBOWDEN, D ;
HAFFNER, S ;
CHESNUT, CH ;
HAZZARD, WR .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 795 (02) :293-296
[4]   INFLUENCE OF NICOTINIC ACID ON SERUM CHOLESTEROL IN MAN [J].
ALTSCHUL, R ;
HOFFER, A ;
STEPHEN, JD .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1955, 54 (02) :558-559
[5]  
*AM DIAB ASS, 1999, DIABETES CARE S1, V22, pS56
[6]  
[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360
[7]  
[Anonymous], 1993, Am J Cardiol, V72, P1031
[8]  
[Anonymous], 1993, Arch Intern Med, V153, P1321
[9]   EFFECTS OF LOVASTATIN THERAPY ON VERY-LOW-DENSITY LIPOPROTEIN TRIGLYCERIDE-METABOLISM IN SUBJECTS WITH COMBINED HYPERLIPIDEMIA - EVIDENCE FOR REDUCED ASSEMBLY AND SECRETION OF TRIGLYCERIDE-RICH LIPOPROTEINS [J].
ARAD, Y ;
RAMAKRISHNAN, R ;
GINSBERG, HN .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (05) :487-493
[10]  
ARAD Y, 1990, J LIPID RES, V31, P567